ArticleThe Kaohsiung journal of medical sciences2025
Circ_0006646 Promotes the Progression of Osteoarthritis via Upregulating CDH11 Expression in an IGF2BP2-Dependent Manner.
Article in The Kaohsiung journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Circ_0006646 Promotes the Progression of Osteoarthritis via Upregulating CDH11 Expression in an IGF2BP2-Dependent Manner.The Kaohsiung journal of medical sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) is a common degenerative osteoarthropathy with an unclear pathogenesis. Circular RNA (circRNA) has been reported to be associated with OA progression. This study aims to explore the role and potential mechanism of hsa_circ_0006646 in OA. Interleukin-1β (IL-1β)-induced human chondrocytes were used as the cell model of OA. RT-qPCR and western blotting were used to detect the expression of circ_0006646, IGF2BP2, and cadherin 11 (CDH11). Cell counting kit-8 assay, 5-ethynyl-2'-deoxyuridine assay, and flow cytometry were performed to assess chondrocyte cell proliferation and apoptosis, respectively. Western blot assay was performed to determine the levels of proliferation-related proteins, apoptosis-related proteins, and extracellular matrix (ECM) proteins. RNA immunoprecipitation (RIP) assay was performed to verify the interaction between IGF2BP2 and circ_0006646 or CDH11. In OA patients and IL-1β-stimulated chondrocytes, circ_0006646 and CDH11 were upregulated. IL-1β suppressed proliferation and induced apoptosis, inflammation, and ECM degradation in chondrocytes, and circ_0006646 knockdown protected chondrocytes from IL-1β-induced damage. IGF2BP2 was proved to interact with both circ_0006646 and CDH11. The overexpression of IGF2BP2 or CDH11 enhanced IL-1β-induced apoptosis, inflammation, and ECM degradation in chondrocytes. Moreover, circ_0006646 absence-mediated effects in IL-1β-treated chondrocytes could be largely overturned by the overexpression of IGF2BP2 or CDH11. In conclusion, circ_0006646 knockdown protected chondrocytes from IL-1β-induced injury by regulating CDH11 in an IGF2BP2-dependent manner, suggesting a novel potential target for OA treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.